Using measurement strategies to identify and monitor residual symptoms

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Psychology

Background:

• Major depressive disorder (MDD) is a chronic condition impacting patient functioning and quality of life.
• Residual symptoms, particularly cognitive dysfunction, persist in many patients post-pharmacotherapy.
• Cognitive impairment significantly influences overall patient outcomes in MDD.

Purpose of the Study:

• To highlight the clinical significance of cognitive dysfunction in MDD.
• To emphasize the need for systematic assessment of cognitive impairment in MDD patients.
• To advocate for targeted interventions for residual cognitive symptoms.

Main Methods:

• Review of current literature on MDD treatment and residual symptoms.
• Analysis of the impact of cognitive dysfunction on patient outcomes.
• Discussion of measurement-based care principles in MDD management.

Main Results:

• Antidepressant monotherapy is insufficient for some MDD patients with residual symptoms.
• Cognitive dysfunction is a common and impactful residual symptom.
• Measurement-based care improves outcomes in MDD.

Conclusions:

• Patients with MDD often require additional interventions beyond initial pharmacotherapy to address cognitive dysfunction.
• Probing, screening, and measuring cognitive impairment are essential components of comprehensive MDD care.
• Effective management of cognitive dysfunction is key to improving long-term patient functioning and quality of life in MDD.